Brief: Fresh Tracks Announces $8.25 Mln Buyout Of Its Right To Receive Future Sofpironium Bromide Payments From Botanix
July 21 (Reuters) - Botanix Pharmaceuticals Ltd
BOT.AX :
* FRESH TRACKS ANNOUNCES $8.25 MILLION BUYOUT OF ITS RIGHT
TO
RECEIVE FUTURE SOFPIRONIUM BROMIDE PAYMENTS FROM BOTANIX
* FRESH TRACKS THERAPEUTICS - UNDER APA AMENDMENT, BOTANIX
TO PAY
$8.25 MILLION IN CASH IN LIEU OF REMAINING AMOUNTS POTENTIALLY
PAYABLE BY BOTANIX TO CO
Source text for Eikon: ID:nGNX55Bfgh
Further company coverage: BOT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million